FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3049175504> ?p ?o ?g. }

• W3049175504 endingPage "96" @default.
• W3049175504 startingPage "85" @default.
• W3049175504 abstract "Background Prevention of mother-to-child transmission (MTCT) of hepatitis B virus (HBV) involves neonatal immunoprophylaxis, with a birth dose of hepatitis B vaccine and immune globulin, and provision of peripartum antiviral prophylaxis in highly viraemic women. However, access to assays to quantify HBV DNA levels remains inadequate in resource-poor settings. This study was commissioned by WHO and aimed to identify the HBV DNA threshold for MTCT, to assess the sensitivity and specificity of hepatitis B e antigen (HBeAg) testing to identify pregnant women with HBV DNA levels above this threshold, and to predict MTCT of HBV infection on the basis of HBeAg testing. Methods For this systematic review and meta-analysis, we searched the PubMed, EMBASE, Scopus, CENTRAL, CNKI, and Wanfang databases for studies of pregnant women with chronic HBV infection without concurrent antiviral therapy, published between Jan 1, 2000, and April 3, 2019. Studies were eligible for inclusion if MTCT in mother–child pairs could be stratified by different levels of maternal HBV DNA during pregnancy, if maternal HBeAg status could be stratified by HBV DNA level, and if the MTCT status of infants could be stratified by maternal HBeAg status during pregnancy. Studies that selected pregnant women on the basis of HBeAg serostatus or HBV DNA levels were excluded. Aggregate data were extracted from eligible studies by use of a pre-piloted form; study authors were contacted to clarify any uncertainties about potential duplication or if crucial information was missing. To pool sensitivities and specificities of maternal HBeAg to identify highly viraemic women and to predict MTCT events, we used the DerSimonian-Laird bivariate random effects model. This study is registered with PROSPERO, CRD42019138227. Findings Of 9007 articles identified, 67 articles (comprising 66 studies) met the inclusion criteria. The risk of MTCT despite infant immunoprophylaxis was negligible (0·04%, 95% CI 0·00–0·25) below a maternal HBV DNA level of 5·30 log10 IU/mL (200 000 IU/mL) and increased above this threshold. The pooled sensitivity of HBeAg testing to identify HBV DNA levels of 5·30 log10 IU/mL or greater in pregnant women was 88·2% (83·9–91·5) and pooled specificity was 92·6% (90·0–94·5). The pooled sensitivity of HBeAg testing in predicting MTCT of HBV infection despite infant immunoprophylaxis was 99·5% (95% CI 91·7–100) and pooled specificity was 62·2% (55·2–68·7). Interpretation Maternal HBV DNA of 5·30 log10 IU/mL or greater appears to be the optimal threshold for MTCT of HBV infection despite infant immunoprophylaxis. HBeAg is accurate to identify women with HBV DNA levels above this threshold and has high sensitivity to predict cases of immunoprophylaxis failure. In areas where HBV DNA assays are unavailable, HBeAg can be used as an alternative to assess eligibility for antiviral prophylaxis. Funding World Health Organization. Prevention of mother-to-child transmission (MTCT) of hepatitis B virus (HBV) involves neonatal immunoprophylaxis, with a birth dose of hepatitis B vaccine and immune globulin, and provision of peripartum antiviral prophylaxis in highly viraemic women. However, access to assays to quantify HBV DNA levels remains inadequate in resource-poor settings. This study was commissioned by WHO and aimed to identify the HBV DNA threshold for MTCT, to assess the sensitivity and specificity of hepatitis B e antigen (HBeAg) testing to identify pregnant women with HBV DNA levels above this threshold, and to predict MTCT of HBV infection on the basis of HBeAg testing. For this systematic review and meta-analysis, we searched the PubMed, EMBASE, Scopus, CENTRAL, CNKI, and Wanfang databases for studies of pregnant women with chronic HBV infection without concurrent antiviral therapy, published between Jan 1, 2000, and April 3, 2019. Studies were eligible for inclusion if MTCT in mother–child pairs could be stratified by different levels of maternal HBV DNA during pregnancy, if maternal HBeAg status could be stratified by HBV DNA level, and if the MTCT status of infants could be stratified by maternal HBeAg status during pregnancy. Studies that selected pregnant women on the basis of HBeAg serostatus or HBV DNA levels were excluded. Aggregate data were extracted from eligible studies by use of a pre-piloted form; study authors were contacted to clarify any uncertainties about potential duplication or if crucial information was missing. To pool sensitivities and specificities of maternal HBeAg to identify highly viraemic women and to predict MTCT events, we used the DerSimonian-Laird bivariate random effects model. This study is registered with PROSPERO, CRD42019138227. Of 9007 articles identified, 67 articles (comprising 66 studies) met the inclusion criteria. The risk of MTCT despite infant immunoprophylaxis was negligible (0·04%, 95% CI 0·00–0·25) below a maternal HBV DNA level of 5·30 log10 IU/mL (200 000 IU/mL) and increased above this threshold. The pooled sensitivity of HBeAg testing to identify HBV DNA levels of 5·30 log10 IU/mL or greater in pregnant women was 88·2% (83·9–91·5) and pooled specificity was 92·6% (90·0–94·5). The pooled sensitivity of HBeAg testing in predicting MTCT of HBV infection despite infant immunoprophylaxis was 99·5% (95% CI 91·7–100) and pooled specificity was 62·2% (55·2–68·7). Maternal HBV DNA of 5·30 log10 IU/mL or greater appears to be the optimal threshold for MTCT of HBV infection despite infant immunoprophylaxis. HBeAg is accurate to identify women with HBV DNA levels above this threshold and has high sensitivity to predict cases of immunoprophylaxis failure. In areas where HBV DNA assays are unavailable, HBeAg can be used as an alternative to assess eligibility for antiviral prophylaxis." @default.
• W3049175504 created "2020-08-21" @default.
• W3049175504 creator A5015302023 @default.
• W3049175504 creator A5022575375 @default.
• W3049175504 creator A5027979621 @default.
• W3049175504 creator A5038204090 @default.
• W3049175504 creator A5045537483 @default.
• W3049175504 creator A5049351433 @default.
• W3049175504 creator A5053233272 @default.
• W3049175504 creator A5055226557 @default.
• W3049175504 creator A5061095714 @default.
• W3049175504 creator A5066514386 @default.
• W3049175504 creator A5070395523 @default.
• W3049175504 creator A5070442023 @default.
• W3049175504 date "2021-01-01" @default.
• W3049175504 modified "2023-10-14" @default.
• W3049175504 title "Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis" @default.
• W3049175504 cites W1599401828 @default.
• W3049175504 cites W1599791623 @default.
• W3049175504 cites W1799522345 @default.
• W3049175504 cites W1850144958 @default.
• W3049175504 cites W1937881082 @default.
• W3049175504 cites W1964721258 @default.
• W3049175504 cites W1968726968 @default.
• W3049175504 cites W1973457659 @default.
• W3049175504 cites W1982954318 @default.
• W3049175504 cites W1995318027 @default.
• W3049175504 cites W1998676987 @default.
• W3049175504 cites W2013582116 @default.
• W3049175504 cites W2014482581 @default.
• W3049175504 cites W2015959530 @default.
• W3049175504 cites W2023338783 @default.
• W3049175504 cites W2032314289 @default.
• W3049175504 cites W2034561831 @default.
• W3049175504 cites W2035233693 @default.
• W3049175504 cites W2038605673 @default.
• W3049175504 cites W2046844651 @default.
• W3049175504 cites W2063568759 @default.
• W3049175504 cites W2075286627 @default.
• W3049175504 cites W2088427919 @default.
• W3049175504 cites W2107638293 @default.
• W3049175504 cites W2115942625 @default.
• W3049175504 cites W2118011635 @default.
• W3049175504 cites W2130750738 @default.
• W3049175504 cites W2131192419 @default.
• W3049175504 cites W2131584918 @default.
• W3049175504 cites W2133564174 @default.
• W3049175504 cites W2146134142 @default.
• W3049175504 cites W2157321867 @default.
• W3049175504 cites W2159739797 @default.
• W3049175504 cites W2166875089 @default.
• W3049175504 cites W2170611757 @default.
• W3049175504 cites W2174723704 @default.
• W3049175504 cites W2194357657 @default.
• W3049175504 cites W2329454428 @default.
• W3049175504 cites W2347053742 @default.
• W3049175504 cites W2509386590 @default.
• W3049175504 cites W2519582915 @default.
• W3049175504 cites W2520996611 @default.
• W3049175504 cites W2523136893 @default.
• W3049175504 cites W2605785536 @default.
• W3049175504 cites W2618139062 @default.
• W3049175504 cites W2739073359 @default.
• W3049175504 cites W2739200525 @default.
• W3049175504 cites W2765454010 @default.
• W3049175504 cites W2767054112 @default.
• W3049175504 cites W2770758743 @default.
• W3049175504 cites W2791491645 @default.
• W3049175504 cites W2791777903 @default.
• W3049175504 cites W2791839818 @default.
• W3049175504 cites W2792632289 @default.
• W3049175504 cites W2801666689 @default.
• W3049175504 cites W2802497431 @default.
• W3049175504 cites W2806975551 @default.
• W3049175504 cites W2809130219 @default.
• W3049175504 cites W2829723541 @default.
• W3049175504 cites W2897644894 @default.
• W3049175504 cites W2921053490 @default.
• W3049175504 cites W2923218959 @default.
• W3049175504 cites W2940868617 @default.
• W3049175504 cites W2942256774 @default.
• W3049175504 cites W2956066265 @default.
• W3049175504 cites W2962944274 @default.
• W3049175504 cites W2993968065 @default.
• W3049175504 doi "https://doi.org/10.1016/s1473-3099(20)30593-4" @default.
• W3049175504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32805201" @default.
• W3049175504 hasPublicationYear "2021" @default.
• W3049175504 type Work @default.
• W3049175504 sameAs 3049175504 @default.
• W3049175504 citedByCount "65" @default.
• W3049175504 countsByYear W30491755042020 @default.
• W3049175504 countsByYear W30491755042021 @default.
• W3049175504 countsByYear W30491755042022 @default.
• W3049175504 countsByYear W30491755042023 @default.
• W3049175504 crossrefType "journal-article" @default.
• W3049175504 hasAuthorship W3049175504A5015302023 @default.
• W3049175504 hasAuthorship W3049175504A5022575375 @default.
• W3049175504 hasAuthorship W3049175504A5027979621 @default.

• next